Practical Considerations for the Validation of Next-Generation Sequencing-Based Oncology Panels

Enroll

  • This content was reviewed no later than 3 years post-recording; CPC determined it was still useful and relevant; an update was recommended. 
  • Revised and/or updated educational content is anticipated with the release of the associated guideline / manuscript update.
  • Content is scheduled for review at 6 years post-recording.

Please note that in the time since this material was published, there may have been additional developments, advancements, and/or more current publications in this field. Please contact AMPClinicalPractice@amp.org with questions or concerns.

Description: 

Validation of NGS-based testing for oncology panels can be challenging given the many steps and wide range of targeted mutations. In this presentation, Dr. Jennings will discuss the recent AMP/CAP guideline recommendations for validation and review practical ways to provide documented evidence with the clinical NGS reports.

Learning Objectives:

  • Describe an error-based approach to validation and choose which sources of variation need to be assessed.
  • Estimate the number of samples that are needed to confidently achieve a stated reliability.
  • Use tolerance limits to define minimum QC performance criteria.
  • Compare ways to assess library complexity.

Practice Guideline Available Here

Speaker: Lawrence J. Jennings, MD, PhD
Moderator: Antonia R. Sepulveda, MD, PhD
Duration: 1 hr
Level of Instruction: Basic
Date Recorded: April 25, 2018

Continuing Education Credit Information

CE Credit for this course has expired.

Note: Join the AMP Family for discounted access to the most current educational resources!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Enroll